Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

AKLI

Akili Inc

May 02 • 04:00PM ET

0.4088

Dollar change +0.0163
Percentage change 4.15	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWC VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.76	Insider Own	32.82%	Shs Outstand	78.36M	Perf Week	67.89%
Market Cap	32.13M	Forward P/E	-	EPS next Y	-0.46	Insider Trans	0.00%	Shs Float	52.80M	Perf Month	61.97%
Income	-59.49M	PEG	-	EPS next Q	-0.14	Inst Own	38.69%	Short Float	0.15%	Perf Quarter	63.52%
Sales	1.68M	P/S	19.13	EPS this Y	27.14%	Inst Trans	19.93%	Short Ratio	0.02	Perf Half Y	14.80%
Book/sh	0.75	P/B	0.55	EPS next Y	9.80%	ROA	-	Short Interest	0.08M	Perf Year	-62.50%
Cash/sh	0.96	P/C	0.43	EPS next 5Y	-	ROE	-	52W Range	0.19 - 1.67	Perf YTD	-16.07%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-93.39%	52W High	-75.52%	Beta	1.69
Dividend TTM	-	Quick Ratio	6.02	Sales past 5Y	209.75%	Gross Margin	51.19%	52W Low	113.81%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	6.02	EPS Y/Y TTM	-167.73%	Oper. Margin	-3842.97%	RSI (14)	71.54	Volatility	16.47% 12.05%
Employees	-	Debt/Eq	0.23	Sales Y/Y TTM	-	Profit Margin	-3545.47%	Recom	2.00	Target Price	0.65
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	-118.66%	Payout	-	Rel Volume	0.35	Prev Close	0.39
Sales Surprise	-6.38%	EPS Surprise	33.33%	Sales Q/Q	813.41%	Earnings	May 14 AMC	Avg Volume	3.87M	Price	0.41
SMA20	59.02%	SMA50	42.46%	SMA200	-22.12%	Trades		Volume	1,370,038	Change	4.15%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-18-22	Initiated	BofA Securities	Neutral	$2
Oct-25-22	Initiated	Credit Suisse	Outperform	$5
Sep-06-22	Initiated	Cowen	Outperform

Apr-30-24 12:45PM	AGBA Stock Pops 35% on Triller Merger Update (InvestorPlace) +70.29%
12:28PM	Why Is Akili (AKLI) Stock Up 68% Today? (InvestorPlace)
08:00AM	Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results (Business Wire)
Feb-29-24 04:01PM	Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire) -7.81%
Feb-27-24 02:00AM	PureTech Founded Entity Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan (Business Wire)
01:51PM	Loading…
Feb-26-24 01:51PM	Why Is Akili (AKLI) Stock Up 110% Today? (InvestorPlace) +104.11%
08:47AM	Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan (Business Wire)
Feb-21-24 04:05PM	Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates (Business Wire) -10.59%
Jan-15-24 09:55AM	Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Dec-29-23 08:22AM	Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years (Insider Monkey)
Dec-21-23 12:00PM	Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-18-23 08:00AM	EndeavorRx, Worlds First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17 (Business Wire) +16.23%
Nov-13-23 09:36AM	Akili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:02PM	Akili Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Oct-19-23 12:27PM	Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET (Business Wire) -8.24%
08:00AM	Loading…
Oct-12-23 08:00AM	Employees with ADHD Arent Reaching Their Full Potential at Work, Akili Study Finds (Business Wire)
Oct-06-23 07:00AM	Akili Announces Leadership Transition (Business Wire)
Sep-21-23 08:00AM	Akili Releases EndeavorOTC on Android Devices, Expanding Treatment Access for Millions of Adults with ADHD (Business Wire) -16.06%
Sep-15-23 03:03AM	Insider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili Inc (GuruFocus.com) -28.66%
Sep-13-23 01:16PM	Digital health startup Akili cuts staff by 40%, abandons prescription model (American City Business Journals)
08:00AM	Akili Announces Business Transformation, Focusing on Non-prescription Model (Business Wire)
Aug-14-23 09:26AM	Akili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 06:43AM	Q2 2023 Akili Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:01PM	Akili Reports Second Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Jul-10-23 07:00AM	Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET (Business Wire)
Jun-08-23 01:20PM	EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults (Benzinga)
Jun-07-23 07:00AM	Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD (Business Wire)
May-31-23 07:00AM	Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress (Business Wire)
May-12-23 11:12AM	Q1 2023 Akili Inc Earnings Call (Thomson Reuters StreetEvents) +11.90%
May-11-23 04:01PM	Akili Reports First Quarter 2023 Financial Results and Provides Business Update (Business Wire)
02:00AM	Loading…
May-04-23 02:00AM	PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akilis EndeavorRx® Video Game-Based Therapeutic (Business Wire) -6.88%
May-03-23 04:56PM	Game-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioning (Benzinga) +46.79%
07:00AM	Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akilis EndeavorRx® Video Game-Based Therapeutic (Business Wire)
Apr-13-23 08:00AM	Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET (Business Wire)
Mar-13-23 11:51AM	Akili, Inc. (NASDAQ:AKLI) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.97%
Mar-08-23 08:32AM	Q4 2022 Akili Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 04:01PM	Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire) -5.38%
Feb-08-23 11:37AM	Akili, Inc.'s (NASDAQ:AKLI) market cap up US$26m last week, benefiting both individual investors who own 26% as well as insiders (Simply Wall St.) +14.74%
Feb-06-23 07:00AM	Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET (Business Wire)
Feb-02-23 07:00AM	Akili to Participate in the Cowen 43rd Annual Health Care Conference (Business Wire)
Jan-06-23 10:43AM	Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference (Business Wire) -14.07%
Jan-05-23 07:00AM	Pivotal Trial of EndeavorRx in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes (Business Wire) +25.00%
Dec-29-22 02:44PM	Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View (Benzinga) +5.97%
Dec-27-22 11:05AM	Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years (Insider Monkey) -13.79%
Dec-01-22 07:00AM	Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer (Business Wire) +10.96%
Nov-19-22 07:52AM	Akili Third Quarter 2022 Earnings: EPS: US$1.38 (vs US$16.67 loss in 3Q 2021) (Simply Wall St.)
Nov-10-22 04:01PM	Akili Reports Third Quarter 2022 Financial Results and Company Update (Business Wire)
Nov-01-22 11:53AM	Down More Than 50%: These 3 Strong Buy Stocks Are Too Cheap to Ignore (TipRanks) +5.45%
Oct-27-22 07:00AM	Financial Industry Veteran Mary Hentges Joins Akilis Board of Directors (Business Wire) -5.29%
Oct-19-22 07:00AM	Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET (Business Wire)
Sep-21-22 07:00AM	Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry (Business Wire) -9.84%
Sep-19-22 07:00AM	Akili to Participate in LifeSci Partners HealthTech Symposium (Business Wire) -14.03%
Aug-22-22 04:08PM	Akili 'took the last decade to clinically validate' its video game treatment for ADHD: CEO (Yahoo Finance Video) -49.18%

Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain. The company was founded by W. Edward Martucci II and Adam Gazzaley in December 2020 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Martucci Walter Edward II	Chief Executive Officer	Sep 11 '23	Sale	1.05	2,353	2,471	3,150,180	Sep 14 08:30 AM
Franklin Matthew	President & COO	Sep 11 '23	Sale	1.05	1,728	1,814	753,898	Sep 14 08:29 AM
Studer Jacqueline	Chief Legal Officer	Sep 11 '23	Sale	1.05	1,130	1,186	348,292	Sep 14 08:31 AM
Shanbhag Santosh	Chief Financial Officer	Sep 11 '23	Sale	1.05	830	872	323,636	Sep 14 08:28 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AKLI

Akili Inc

Upgrade your FINVIZ experience